Fiona Thomson - Concepedia

Author

Fiona Thomson

Also Known As

F J Thomson, F THOMSON, F Thomson, F. J. THOMSON, F. J. Thomson, F. Thomson, F.J. Thomson, FIONA J. THOMSON, FIONA THOMSON, Fiona J Thomson

362

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Glasgow University of Bristol University of Strathclyde Merck & Co., Inc., Rahway, NJ, USA (United States)University of Liverpool

About

Fiona Thomson is an author at University of Glasgow specializing in medicine, pharmacology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	800
2	Natural Sciences	3	3	71
3	Engineering	1	1	19
4	Health Sciences	1	1	26
5	Public Health	1	1	29

Fiona Thomson

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Allosteric Modulation of the Cannabinoid CB1 Receptor M. R. Price, Gemma L. Baillie, Adèle Thomas, Molecular Pharmacology	2005	440
Obstetric outcome in women with subfertility Fiona Thomson, Smrutha Shanbhag, Allan Templeton, BJOG An International Journal of Obstetrics & Gynaecology	2005	167
Three-dimensional CT angiography in the detection and characterization of intracranial berry aneurysms. J. K. A. Hope, Jane Wilson, Fiona Thomson PubMed	1996	134
A team approach to diabetic foot care—the Manchester experience Fiona Thomson, Aristidis Veves, H. Ashe, The Foot Health PolicyTeam ApproachDiabetesDiabetic NeuropathyPodiatry	1991	130
Persistent cough in children and the overuse of medications Fiona Thomson, IB Masters Journal of Paediatrics and Child Health	2002	128
The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells Gwyn W. Gould, Ana Cuenda, Fiona Thomson, Biochemical Journal	1995	91
The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. J A Thomson, Kyle A. Murphy, Elizabeth Baker, PubMed	1995	86
Lack of Knowledge of Symptoms of Hypoglycaemia by Elderly Diabetic Patients Fiona Thomson, E. A. Masson, J. T. Leeming, Age and Ageing Metabolic SyndromeFamily MedicineDiabetes ManagementWarning SymptomsCardiovascular Disease	1991	86
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease Gillian A. Horne, Jon Stobo, Caroline Kelly, Leukemia Hematological MalignancyResidual DiseaseImatinib Versus ImatinibMedicineChronic Myeloid Leukaemia	2020	75
ACTIVATION OF MAP KINASE ASSOCIATED WITH THE PRIMING EFFECT OF LHRH Robert M. Mitchell, Pauline Sim, Traci Leslie, Journal of Endocrinology Signaling PathwayPituitary GlandCell SignalingMolecular PhysiologyEndocrine Mechanism	1994	67

Page 1